ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,016, issued on Nov. 3, was assigned to IP2IPO Innovations Ltd. (London).
"Appetite suppressing compounds" was invented by Stephen Robert Bloom (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "PYY-derived compounds comprising residues changed from the naturally-occurring peptide sequence and substituted, for example at their gamma-carboxylic acid groups, epsilon-amino groups or alpha-amino groups, with fatty dioic acid groups either directly or via short pendant oligopeptides. Related methods, compositions and uses, in particular for use in appetite suppression and the treatment or prevention of diabetes or obesity."
The patent was filed on Jun...